Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Depression 2Unipolar Major Depression 1Radiation Injuries 1Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Depressive Disorder, Major 1

Interventions

Therapeutics 28Psychiatric Rehabilitation 21Surveys and Questionnaires 14Cognitive Behavioral Therapy 12Psilocybin 8Methods 8Ketamine 8Early Intervention, Educational 8Saline Solution 7Yoga 6Mindfulness-Based Cognitive Therapy 6Interviews as Topic 6Esketamine 6Psychosocial Intervention 5Mindfulness 5Escitalopram 5Behavior Therapy 5Methylphenidate 4Exercise Therapy 4Exercise 4Educational Status 4Counseling 4Control Groups 4Acupuncture Therapy 4Standard of Care 3Psychotherapy 3Palliative Care 3Niacin 3Mindfulness-Based Stress Reduction 3Melatonin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Depression × Vortioxetine × Clear all
NCT04818099 2021-03-26

Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3 Unknown
208 enrolled
Head & Neck

Depression, Head and Neck Neoplasms, Radiation Injuries

NCT04253678 2020-02-05

Vortioxetine for Cancer Patients With Depression: An Observational Study

University of Malaya

Unknown
140 enrolled

Depression, Depressive Disorder, Major, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡